Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 38 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 8187605

    Means for the inhibition of anti-β1-adrenergic receptor antibodies

    Julius-Maximilians-Universitat Wurzburg · Granted May 29, 2012 · Expires May 24, 2032

    granted

  2. US 8173673

    Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and the use thereof

    Julius-Maximilians-Universitat Wurzburg · Granted May 8, 2012 · Expires May 3, 2032

    granted

  3. US 8168591

    Compositions and methods related to anti-FGF agents

    The Regents of the University of California · Granted May 1, 2012 · Expires Apr 26, 2032

    granted

  4. US 8163509

    Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  5. US 8143390

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Alnylam Pharmaceuticals, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted

  6. US 8137672

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted

  7. US 8133859

    SCGB3A2 as a growth factor and anti-apoptotic agent

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted

  8. US 8128930

    Anti-ADDL antibodies and uses thereof

    Northwestern University · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted

  9. US 2012029034

    Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents

    AMMENDOLA ALDO [DE] · Granted Feb 2, 2012 · Expires Jan 28, 2032

    granted

  10. US 8097713

    Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted

  11. US 8088774

    Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

    Northwestern University · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  12. US 8088729

    Anti-viral griffithsin compounds, compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  13. US 8088908

    Humanized anti-prostate stem cell antigen monoclonal antibody

    The Regents of the University of California · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  14. US 8076372

    Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The Government of the United States · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  15. US 8053422

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  16. US 8038997

    Anti-marinobufagenin antibodies and methods for their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  17. US 8039257

    Pre-transplant accomodated organs resistant to anti-donor immunity

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  18. US 8039585

    Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  19. US 8029788

    Variants of humanized anti-carcinoma MAb CC49

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  20. US 8021644

    Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis

    The Regents of the University of California · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  21. US 8022175

    Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases viruses from vaccine strains of Newcastle disease virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  22. US 8012946

    Anti-angiogenic methods and compositions

    Sangamo Biosciences, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  23. US 7999082

    Anti-factor B antibodies

    The Regents of the University of Colorado · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  24. US 7993648

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.